Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Liraglutide Injection

Approval Number

国药准字S20233110

Company杭州中美华东制药有限公司

Registration Date

June 30, 2023

Drug Information

Generic Name

利拉鲁肽注射液

Trade Name

利鲁平

Dosage Form

注射剂

Strength

3ml:18mg（笔芯）

Drug Type

生物制品

Registration Date

June 30, 2023

Company Information

Applicant Company

Company Name杭州中美华东制药有限公司

Company Address

杭州市莫干山路866号祥符桥

Manufacturing Company

Company Name杭州九源基因工程股份有限公司

Company Address

杭州经济技术开发区八号大街东

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利拉鲁肽注射液 - NMPA 批准文号 | MedPath